Next Article in Journal
Pesticide Exposure, Safety Issues, and Risk Assessment Indicators
Next Article in Special Issue
Polycyclic Aromatic Hydrocarbon (PAH) Exposure and DNA Adduct Semi-Quantitation in Archived Human Tissues
Previous Article in Journal
Spatial Multicriteria Decision Analysis of Flood Risks in Aging-Dam Management in China: A Framework and Case Study
Previous Article in Special Issue
IL8 and Cathepsin B as Melanoma Serum Biomarkers
Int. J. Environ. Res. Public Health 2011, 8(5), 1388-1401; doi:10.3390/ijerph8051388
Review

Biomarkers of Immunotoxicity for Environmental and Public Health Research

1
 and 2,*
Received: 18 February 2011; in revised form: 26 March 2011 / Accepted: 25 April 2011 / Published: 6 May 2011
(This article belongs to the Special Issue Biomarkers: Environmental Research and Public Health)
View Full-Text   |   Download PDF [219 KB, updated 19 June 2014; original version uploaded 19 June 2014]   |   Browse Figure
Abstract: The immune response plays an important role in the pathophysiology of numerous diseases including asthma, autoimmunity and cancer. Application of biomarkers of immunotoxicity in epidemiology studies and human clinical trials can improve our understanding of the mechanisms that underlie the associations between environmental exposures and development of these immune-mediated diseases. Immunological biomarkers currently used in environmental health studies include detection of key components of innate and adaptive immunity (e.g., complement, immunoglobulin and cell subsets) as well as functional responses and activation of key immune cells. The use of high-throughput assays, including flow cytometry, Luminex, and Multi-spot cytokine detection methods can further provide quantitative analysis of immune effects. Due to the complexity and redundancy of the immune response, an integrated assessment of several components of the immune responses is needed. The rapidly expanding field of immunoinformatics will also aid in the synthesis of the vast amount of data being generated. This review discusses and provides examples of how the identification and development of immunological biomarkers for use in studies of environmental exposures and immune-mediated disorders can be achieved.
Keywords: asthma; COPD; biomarker validation; immunoinformatics; Luminex; immunome; immunotoxicity asthma; COPD; biomarker validation; immunoinformatics; Luminex; immunome; immunotoxicity
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Duramad, P.; Holland, N.T. Biomarkers of Immunotoxicity for Environmental and Public Health Research. Int. J. Environ. Res. Public Health 2011, 8, 1388-1401.

AMA Style

Duramad P, Holland NT. Biomarkers of Immunotoxicity for Environmental and Public Health Research. International Journal of Environmental Research and Public Health. 2011; 8(5):1388-1401.

Chicago/Turabian Style

Duramad, Paurene; Holland, Nina T. 2011. "Biomarkers of Immunotoxicity for Environmental and Public Health Research." Int. J. Environ. Res. Public Health 8, no. 5: 1388-1401.


Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert